Tobias Brandt
Overview
Explore the profile of Tobias Brandt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engelter S, Enz L, Ravanelli F, Kaufmann J, Gensicke H, Schaedelin S, et al.
Eur Stroke J
. 2025 Feb;
:23969873251315362.
PMID: 39910883
Introduction: Cervical artery dissection is a major cause of stroke in the young. The optimal choice and duration of antithrombotic treatment for stroke prevention are debated, particularly beyond 3 months...
2.
Tometten I, Brandt T, Schlotz M, Stumpf R, Landmann S, Kantauskaite M, et al.
Front Immunol
. 2025 Jan;
15:1476294.
PMID: 39877366
Background: The emergence of novel SARS-CoV-2 variants challenges immunity, particularly among immunocompromised kidney transplant recipients (KTRs). To address this, vaccines have been adjusted to circulating variants. Despite intensive vaccination efforts,...
3.
Klimpel M, Terrao M, Brauer M, Dersch H, Biserni M, Melo Do Nascimento L, et al.
Biotechnol J
. 2024 May;
19(5):e2400090.
PMID: 38719592
The production of lentiviral vectors (LVs) pseudotyped with the vesicular stomatitis virus envelope glycoprotein (VSV-G) is limited by the associated cytotoxicity of the envelope and by the production methods used,...
4.
Vogel J, Terrao M, Schwingal S, Kapitza L, Brigulla D, Pirzas V, et al.
Biotechnol J
. 2024 Mar;
19(3):e2300348.
PMID: 38472091
The development and manufacture of biopharmaceuticals are subject to strict regulations that specify the required minimum quality of the products. A key measure to meet these quality requirements is the...
5.
Kornek D, Menichelli D, Leske J, Hofmann M, Antkiewicz D, Brandt T, et al.
Z Med Phys
. 2023 Sep;
34(3):371-383.
PMID: 37666699
Before introducing new treatment techniques, an investigation of hazards due to unintentional radiation exposures is a reasonable activity for proactively increasing patient safety. As dedicated software is scarce, we developed...
6.
Masitho S, Grigo J, Brandt T, Lambrecht U, Szkitsak J, Weiss A, et al.
Strahlenther Onkol
. 2023 Jun;
199(8):739-748.
PMID: 37285037
Purpose: Auxiliary devices such as immobilization systems should be considered in synthetic CT (sCT)-based treatment planning (TP) for MRI-only brain radiotherapy (RT). A method for auxiliary device definition in the...
7.
Shariff M, Grigo J, Masitho S, Brandt T, Weiss A, Lambrecht U, et al.
Z Med Phys
. 2022 Dec;
34(3):477-484.
PMID: 36539322
Purpose: A new insert for a commercially available end-to-end test phantom was designed and in-house manufactured by 3D printing. Subsequently, the insert was tested for different stereotactic radiation therapy workflows...
8.
Engelter S, Traenka C, Grond-Ginsbach C, Brandt T, Hakimi M, Worrall B, et al.
Front Neurol
. 2021 Jun;
12:663830.
PMID: 34135851
Cervical artery dissection (CeAD) occurring in the context of sports is a matter of concern for CeAD patients. They seek advice on the role of sports in CeAD and on...
9.
Witulla B, Ziegler M, Brandt T, Prasetio H, Fietkau R, Bert C
Z Med Phys
. 2021 Feb;
31(4):388-393.
PMID: 33622568
The purpose of this work was to develop a treatment plan verification routine for a linear accelerator dedicated to SBRT treatments with gimbal based dynamic tumor tracking using three commercially...
10.
Brandt T, Wagner S, Neumann D
Eur J Oper Res
. 2020 Oct;
291(1):379-393.
PMID: 33041471
In this work, we investigate the challenges public-sector organizations face when seeking to leverage prescriptive analytics and provide insights into the public value such data-driven tools and methods can provide....